Anthacyclines in non-small cell lung cancer

被引：0
|
作者：
Pronzato, P [1 ]
Vigani, A
Tognoni, A
Vaira, F
Canessa, P
机构：
[1] Osped S Angrea, Dept Med Oncol, I-19100 La Spezia, Italy
[2] Osped S Andrea, Dept Pneumol, I-19100 La Spezia, Italy
来源：
LUNG CANCER | 2001年 / 34卷
关键词：
non-small cell lung cancer; chemotherapy; anthracyclines;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The literature concerning the use of anthracyclines in the treatment of non-small cell lung cancer (NSCLC) is reviewed here. Overall. the activity of doxorubicin (DOXO) is unsatisfactory, whereas, the analogous epidoxorubicin (EPI) yields a 30% response rate (RR) when administered at intermediate-high doses. All active drugs, including EPI. should be considered to design the most active combination. Mainly. in the setting. in which an objective response is very important. for instance the neo-adjuvant pre-operatory setting. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码：S57 / S59
页数：3
相关论文
共 50 条
  • [41] Staging of non-small cell lung cancer
    Tanoue, Lynn T.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2008, 29 (03) : 248 - 260
  • [42] Non-small cell lung cancer in the elderly
    Provencio, Mariano
    Camps, Carlos
    Cantos, Blanca
    Alberola, Vicente
    Domine, Manuel
    Isla, Dolores
    Millan, Isabel
    Massuti, Bartomeu
    Cardenal, Felipe
    Rosell, Rafael
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S453 - S453
  • [43] Pneumonectomy for Non-Small Cell Lung Cancer
    Sugarbaker, David J.
    Haywood-Watson, Ricky J.
    Wald, Ori
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2016, 25 (03) : 533 - +
  • [44] Radiotherapy for non-small cell lung cancer
    Jassem, J
    LUNG CANCER, 2001, 34 : S177 - S180
  • [45] Non-small cell lung cancer -: Introduction
    Bonner, JA
    SEMINARS IN RADIATION ONCOLOGY, 2000, 10 (04) : 263 - 266
  • [46] Mobocertinib in non-small cell lung cancer
    Liu, Shengwu
    Lowder, Kristen E.
    DRUGS OF TODAY, 2022, 58 (11) : 523 - 530
  • [47] Cetuximab in non-small cell lung cancer
    Ademuyiwa, Foluso O.
    Hanna, Nasser
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2008, 8 (01) : 107 - 113
  • [48] Introduction: Non-small cell lung cancer
    Laskin, JJ
    Sandler, AB
    Johnson, DH
    SEMINARS IN ONCOLOGY, 2005, 32 (03) : 251 - 252
  • [49] Chemotherapy in non-small cell lung cancer
    Sweeney, CJ
    Sandler, AB
    INVESTIGATIONAL NEW DRUGS, 2000, 18 (02) : 157 - 186
  • [50] Lymphadenectomy in non-small cell lung cancer
    Gellert, K
    Agnes, A
    Noack, F
    Benhidjeb, T
    Jacobi, C
    ZENTRALBLATT FUR CHIRURGIE, 1996, 121 (02): : 87 - 89
12345